Tumor-specific CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors

被引:0
|
作者
Dragovich, Matthew A.
Davra, Viralkumar
Faber, Matthew S.
Kim, Yoon Kyung
Nisthal, Alex
Zeng, Veronica G.
Jacinto, Jonathan
Diaz, Juan E.
Truong, Thuy
Qi, Jing
Avery, Kendra N.
Rashid, Rumana
Lee, Sung-Hyung
Chu, Seung Y.
Bonzon, Christine
Love, Ruschelle
Bernett, Matthew J.
Ernst, James A.
Bahjat, Rena
Barlow, Norman J.
Desjarlais, John R.
Hedvat, Michael
Moore, Gregory L.
机构
关键词
D O I
10.1158/1538-7445.AM2023-2983
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2983
引用
收藏
页数:3
相关论文
共 50 条
  • [11] Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy
    Waite, Janelle C.
    Wang, Bei
    Haber, Lauric
    Hermann, Aynur
    Ullman, Erica
    Ye, Xuan
    Dudgeon, Drew
    Slim, Rabih
    Ajithdoss, Dharani K.
    Godin, Stephen J.
    Ramos, Ilyssa
    Wu, Qi
    Oswald, Erin
    Poon, Patrick
    Golubov, Jacquelynn
    Grote, Devon
    Stella, Jennifer
    Pawashe, Arpita
    Finney, Jennifer
    Herlihy, Evan
    Ahmed, Hassan
    Kamat, Vishal
    Dorvilliers, Amanda
    Navarro, Elizabeth
    Xiao, Jenny
    Kim, Julie
    Yang, Shao Ning
    Warsaw, Jacqueline
    Lett, Clarissa
    Canova, Lauren
    Schulenburg, Teresa
    Foster, Randi
    Krueger, Pamela
    Garnova, Elena
    Rafique, Ashique
    Babb, Robert
    Chen, Gang
    Oristian, Nicole Stokes
    Siao, Chia-Jen
    Daly, Christopher
    Gurer, Cagan
    Martin, Joel
    Macdonald, Lynn
    MacDonald, Douglas
    Poueymirou, William
    Smith, Eric
    Lowy, Israel
    Thurston, Gavin
    Olson, William
    Lin, John C.
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (549)
  • [12] CD28 AND T-CELL ACTIVATION
    OLIVE, D
    VANLIER, R
    RESEARCH IN IMMUNOLOGY, 1995, 146 (03): : 127 - 129
  • [13] The bispecific antibody KA-3007 against B7H3 and CD28 enhances T cell activation in solid tumors
    Wu, Guojin
    Guo, Zhengcheng
    Peng, Hao
    Hao, Feng
    He, Feng
    Ning, Jinying
    CANCER RESEARCH, 2024, 84 (06)
  • [14] CD28 fails to costimulate tumor-specific activation of Epstein Barr-virus-specific memory effector T cells.
    Altvater, B
    Pscherer, S
    Juergens, H
    Rossig, C
    BLOOD, 2005, 106 (11) : 376A - 377A
  • [15] Fine Tuning Bispecific Activity in CLL: Harmonizing a CD19/20-T Cell Bispecific with a CD28 or 4-1BBL Costimulatory Bispecific
    Rappa, Giulia Petra
    Sponheimer, Monika
    Haenel, Gerulf
    Neumann, Anne-Sophie
    Philipp, Nora
    Korfi, Koorosh
    Herter, Sylvia
    Sam, Johannes
    Schuler, Franz
    Klein, Christian
    Bacac, Marina
    Umana, Pablo
    Subklewe, Marion
    BLOOD, 2023, 142
  • [16] Differentiation and Activation of γδ T Lymphocytes: Focus on CD27 and CD28 Costimulatory Receptors
    Ribot, Julie C.
    Silva-Santos, Bruno
    CROSSROADS BETWEEN INNATE AND ADAPTIVE IMMUNITY IV, 2013, 785 : 95 - 105
  • [17] CD28 AND T-CELL ACTIVATION - DISCUSSION
    LEDBETTER, J
    LINSLEY, P
    LANE, P
    RUDD, CE
    SCHNEIDER, H
    SOMOZA, C
    LANIER, LL
    VANGOOL, SW
    CEUPPENS, JL
    DEBOER, M
    CHIODETTI, L
    SCHWARTZ, RH
    RESEARCH IN IMMUNOLOGY, 1995, 146 (03): : 197 - 205
  • [18] CD28 T-cell costimulatory molecule expression in pemphigus vulgaris
    Alecu, M.
    Ursaciuc, C.
    Surcel, M.
    Coman, G.
    Ciotaru, D.
    Dobre, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (03) : 288 - 291
  • [19] The bispecific antibody KA-3001, targeting PSMA and CD28, specifically enhances T cell activation within prostate tumors
    Liang, Jiabei
    Su, Chen
    Peng, Hao
    Hao, Feng
    Liu, Tongtong
    Ning, Jinying
    Wu, Guojin
    CANCER RESEARCH, 2024, 84 (06)
  • [20] CD28 Costimulatory Domain-Targeted Mutations Enhance Chimeric Antigen Receptor T-cell Function
    Boucher, Justin C.
    Li, Gongbo
    Kotani, Hiroshi
    Cabral, Maria L.
    Morrissey, Dylan
    Lee, Sae Bom
    Spitler, Kristen
    Beatty, Nolan J.
    Cervantes, Estelle, V
    Shrestha, Bishwas
    Yu, Bin
    Kazi, Aslamuzzaman
    Wang, Xuefeng
    Sebti, Said M.
    Davila, Marco L.
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (01) : 62 - 74